Friday - October 9, 2026
Bayer to Present New Cardiac Amyloidosis, Heart Failure Data at Heart Failure Society of America Annual Scientific Meeting
October 09, 2026
WHIPPANY, New Jersey, Oct. 9 [Category: BizPharmaceuticals] -- Bayer USA, an enterprise with core competencies in the life science fields of health care and nutrition, posted the following news:

* * *

October 9, 2026

Bayer to Present New Cardiac Amyloidosis and Heart Failure Data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting

Data from Bayer's cardiovascular portfolio in heart failure and cardiac amyloidosis will . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products